Malignant lymphoma is a very common malignant tumor. How long a patient with malignant lymphoma lives depends mainly on the type of pathology of the patient. For example, angioblast lymphoma, Burkitt’s lymphoma, and T-lymphocytic lymphoma have a relatively short survival period of about one year for patients due to their relatively high malignancy. However, there are some inert lymphomas such as set cell lymphoma and small lymphocytic lymphoma, and these lymphomas progress very slowly. With standard treatment, patients have the potential to survive for 8-10 years or longer. On the whole, the survival of lymphoma depends mainly on the type of pathology and is also related to the patient’s treatment effect. With the improvement of modern treatment technology and the application of new chemotherapeutic drugs, the survival time of lymphoma patients may be further extended. Patients suffering from lymphoma should go to the hospital for scientific and standardized treatment in a timely manner.